Last update Nov. 7, 2024
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Arformoterol Tartrate in other languages or writings:
Arformoterol Tartrate belongs to this group or family:
Variable | Value | Unit |
---|---|---|
Molecular weight | 495 | daltons |
Protein Binding | 52 - 65 | % |
pKa | 8.61 | - |
Tmax | 0.5 - 3 | hours |
T½ | 26 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Amamanta of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
El arformoterol es el enantiómero R,R del agonista del receptor beta2-adrenérgico formoterol. Es un broncodilatador beta-2 adrenérgico selectivo de acción prolonfgada similar al salmeterol. Al igual que el salbutamol, es de características similares a la Terbutalina. Administracion inhalada.
A fecha de la última actualización no encontramos datos publicados sobre su excreción en leche materna.
La absorcion por inhalacion es mínima y los niveles plasmaticos muy bajos.
Su relativamente elevado peso molecular hace improbable su paso a leche.
Diversas sociedades médicas y autores expertos consideran seguro el uso de broncodilatadores inhalados durante la lactancia debido a los bajos niveles séricos maternos. (Hale, Lactmed, Bendien 2024, Amir 2011, National Asthma 2004, Nelson 2001, Ellsworth 1994)